| アイテムタイプ |
学術雑誌掲載論文(1) |
| 公開日 |
2026-03-25 |
| タイトル |
|
|
タイトル |
Phase 3, multicentre, randomised, double-blind, placebo-controlled, parallel-group study of ustekinumab in Japanese patients with active polymyositis and dermatomyositis who have not adequately responded to one or more standard-of-care treatments |
|
言語 |
en |
| 言語 |
|
|
言語 |
eng |
| 著者 |
Kawahata Kimito
Ishii Tomonori
Gono Takahisa
Tsuchiya Yumi
Ohashi Hiroki
Yoshizawa Katsunori
Zheng Richuan
Ayabe Maori
Nishikawa Kazuko
|
| 識別子 |
|
|
識別子 |
https://doi.org/10.1136/rmdopen-2023-003268 |
|
識別子タイプ |
DOI |
| 書誌情報 |
en : JCO precision oncology
巻 9,
号 3,
p. e003268,
発行日 2023-08-31
|
| 出版者 |
|
|
出版者 |
BMJ |
|
言語 |
en |
| 収録物識別子 |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
2056-5933 |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| アクセス権 |
|
|
アクセス権 |
open access |
| 権利情報 |
|
|
権利情報 |
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
e003268.full.pdf (1.7 MB)
.png)
